Published in Brain Res on August 13, 1984
Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proc Natl Acad Sci U S A (2008) 1.73
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol (2003) 1.49
Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance. Br J Pharmacol (2007) 1.00
Neostigmine interactions with non steroidal anti-inflammatory drugs. Br J Pharmacol (2002) 0.92
Combination Drug Therapy for Pain following Chronic Spinal Cord Injury. Pain Res Treat (2012) 0.87
When it comes to opiates, just say NO. J Clin Invest (2007) 0.86
The effect of acute morphine on delay discounting in dependent and non-dependent rats. Psychopharmacology (Berl) (2014) 0.76
Intrathecal morphine in mice: a new technique. Eur J Pharmacol (1980) 5.99
Blunt tracheobronchial injuries: treatment and outcomes. Ann Thorac Surg (2001) 2.41
Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96
Corynebacterium vaginale vaginitis. Review of the literature and presentation of data based on vaginal cultures from 1,008 patients. Am J Obstet Gynecol (1972) 1.87
Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res (1981) 1.61
Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci (2001) 1.50
Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther (1987) 1.42
The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia. Leukemia (2007) 1.42
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40
The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci (1997) 1.37
The role of nitric oxide in hippocampal long-term potentiation. Neuron (1992) 1.33
Cytokine involvement in dynorphin-induced allodynia. Pain (2000) 1.29
Corynebacterium vaginale vaginitis in pregnant women. Am J Clin Pathol (1971) 1.28
Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci (1991) 1.27
Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts. J Am Vet Med Assoc (1998) 1.25
Homoharringtonine: history, current research, and future direction. Cancer (2001) 1.25
Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett (1992) 1.24
Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci (2001) 1.24
Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Exp Ther (1999) 1.23
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain (1996) 1.22
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain (1997) 1.18
Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A (2000) 1.14
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant (2000) 1.12
Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J (1999) 1.06
Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport (1997) 1.04
Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther (1987) 1.03
Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther (1983) 1.00
Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther (2001) 1.00
Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res (1987) 1.00
The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx. Head Neck (2000) 1.00
Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides (1982) 0.99
Can dietary treatment of non-anemic iron deficiency improve iron status? J Am Coll Nutr (2001) 0.98
Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience (2005) 0.96
An instrument using a multiple layer Peltier device to change skin temperature rapidly. Brain Res Bull (1984) 0.95
Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy. Biochem Pharmacol (1996) 0.94
Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med (2001) 0.93
Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther (1997) 0.93
A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain (1996) 0.93
Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther (1992) 0.92
Tumor volume: an independent predictor of outcome for laryngeal cancer. J Comput Assist Tomogr (1999) 0.92
Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport (2000) 0.92
Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett (1986) 0.92
Isolation of two different glucuronide metabolites of naloxone from the urine of rabbit and chicken. J Pharmacol Exp Ther (1969) 0.92
Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther (1993) 0.90
Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol (1998) 0.90
Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience (1999) 0.90
Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci (1983) 0.90
Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain (1990) 0.89
Studies on the antidiuretic action of morphine in the rat. Eur J Pharmacol (1968) 0.89
Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain (1987) 0.87
Intrathecal opioids block a spinal action of substance P in mice: functional importance of both mu- and delta-receptors. Eur J Pharmacol (1982) 0.87
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma (2001) 0.87
Incidence of Haemophilus vaginalis. Am J Obstet Gynecol (1969) 0.87
Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy. Hematol Oncol Clin North Am (1998) 0.86
Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science (1997) 0.86
Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther (1999) 0.85
Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. Neuroreport (1992) 0.85
Different radiant heat intensities differentiate intracerebroventricular morphine- from beta-endorphin-induced inhibition of the tail-flick response in the mouse. Eur J Pharmacol (1992) 0.85
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. Leukemia (2005) 0.85
Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.84
Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther (1989) 0.84
Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology (2000) 0.84
Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558). Proc Soc Exp Biol Med (1975) 0.84
Cardiac excitation-contraction coupling in the portal hypertensive rat. Am J Physiol Gastrointest Liver Physiol (2000) 0.84
Evaluation of a medium for isolation and identification of coagulase positive staphylococci. Am J Med Technol (1968) 0.83
Inhibition of renal tubular transport of morphine by -diethylaminoethyl diphenylpropylacetate in the chicken. Biochem Pharmacol (1971) 0.83
Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice. J Pharmacol Exp Ther (2001) 0.83
The development of tolerance to the antidiuretic effect of morphine in the mouse. Toxicol Appl Pharmacol (1968) 0.82
Prevalence and associations of the metabolic syndrome among patients prescribed clozapine. Ir J Med Sci (2008) 0.82
A phase I study of intermittent infusion cladribine in patients with solid tumors. Cancer (1994) 0.82
The diuretic effect of morphine in the chicken. Eur J Pharmacol (1968) 0.82
Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res Mol Brain Res (1995) 0.82
Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res (1978) 0.82
Evaluation of hepatobiliary function in the rat by the segmented retrograde intrabiliary injection technique. Biochem Pharmacol (1980) 0.81
Absence of cross-tolerance to heroin in morphine-tolerant mice. Science (1980) 0.81
Decitabine studies in chronic and acute myelogenous leukemia. Leukemia (1997) 0.81
Development of tolerance to respiratory depression in morphine- and etorphine-pellet-implanted mice. Brain Res (1987) 0.81
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood (1992) 0.81
Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther (1989) 0.81
Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J Pharmacol Exp Ther (1991) 0.81
Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol (2014) 0.81
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results. Cancer (1995) 0.81
Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein. J Biotechnol (1996) 0.80
Effect of carbon tetrachloride on distribution of sulfobromophthalein in plasma and liver of mice. Toxicol Appl Pharmacol (1966) 0.80
Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci (1994) 0.80
The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice. J Pharmacol Exp Ther (1994) 0.80
Effect of colchicine and S,S,S-tributyl phosphorotrithioate (DEF) on the biliary excretion of sucrose, mannitol and horseradish peroxidase in the rat. Biochem Pharmacol (1983) 0.80
Analgesic potencies of morphine 3- and 6-sulfates after intracerebroventricular administration in mice: relationship to structural characteristics defined by mass spectrometry and nuclear magnetic resonance. J Pharm Sci (1985) 0.80
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia. Int J Lab Hematol (2008) 0.80
Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice. J Pharmacol Exp Ther (2001) 0.80
Spinal plasticity of acute opioid tolerance. J Biomed Sci (2000) 0.80
Mechanism of the renal tubular transport of morphine and morphine ethereal sulfate in the chicken. J Pharmacol Exp Ther (1970) 0.79
A study of absorption of compounds from the rat biliary tree by retrograde intrabiliary injection (RII). J Pharmacol Exp Ther (1975) 0.79